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ABSTRACT  
Histidine-rich glycoprotein (HRG) is a relatively abundant plasma protein that is synthesized by 
parenchymal liver cells. Using Western blot analysis and immunoperoxidase techniques, we have 
previously shown the presence of HRG in human skeletal muscle. This paper reports the results of 
immunofluorescence experiments carried out on sections of human normal skeletal muscle biopsies 
to investigate the subcellular localization of HRG. The HRG localization was also compared with 
that of skeletal muscle AMP deaminase (AMPD1) since we have previously described an 
association of the enzyme with the protein. The obtained results give evidence for a preferential 
localization of HRG at the I-band level, where it shows the same distribution of actin and where 
AMPD1 is present in major concentration.  
 
 
Keywords: Histidine-rich glycoprotein, skeletal muscle, AMP deaminase, metallochaperone, 
immunofluorescence. 
Abbreviations: (HRG) Histidine-rich glycoprotein, (AMPD1) skeletal muscle AMP deaminase, 
(TnT) troponin T, (FGF-2) fibroblast growth factor-2,  (HUVEC) human umbilical vein endothelial 
cells. 
 
 3 
 
INTRODUCTION  
Histidine-rich glycoprotein (HRG), also known as histidine-proline-rich glycoprotein,  is a 75 kDa 
glycoprotein originally isolated and characterized from human serum (Haupt and Heimburger 1972; 
Heimburger et al. 1972) and  later found in the plasma of many other vertebrates where it is present 
at relatively high concentrations (100-150 μg/ml in humans) (Morgan et al. 1978). It is synthesized 
by parenchymal liver cells (Koide et al. 1986) and although it has also been detected in immune 
cells such as monocytes and macrophages (Sia et al. 1982) as well as in the α-granules of platelets 
and in megakaryocytes (Leung et el. 1983), a study on the cellular origin of murine plasma HRG 
has shown that HRG mRNA is produced exclusively in the liver (Hulett and Parish 2000). HRG 
interacts with many ligands including fibrinogen, plasminogen, plasmin, heparin and heparin 
sulphate, IgG, FcgR, C1q, tropomyosin, thrombospondin and divalent transition metal cations such 
as Zn
2+
. Through its multidomain structure, HRG might act as an adaptor protein that brings 
together different ligands under specific conditions, modulating many physiological processes such 
as coagulation, fibrinolysis, cell chemotaxis, immune response, apoptotic process, cell adhesion and 
migration, cell growth and proliferation (Jones et al. 2005). The association of HRG with purified 
rabbit skeletal muscle AMP deaminase (AMPD1) has been previously described by our research 
group (Ranieri-Raggi et al. 1997, 2003). AMPD1, one of the three enzymes of the purine nucleotide 
cycle, catalyzes the deamination of AMP to IMP playing a central role in preserving the adenylate 
energy charge in myocytes following exercise (Lowenstein and Tornheim, 1971). It has also given 
experimental evidence that rabbit HRG hosts two Zn
2+
 ions coordinated by His residues and sulfur 
from cysteine residues strengthening the hypothesis that HRG functions as a metallochaperone in 
the formation of a heterodimer with skeletal muscle AMPD (Mangani et al. 2003; Ranieri-Raggi et 
al. 2014; Ronca and Raggi, 2015).  
We have provided the first evidence for the presence of HRG in human skeletal muscle showing 
that an antibody against human plasma HRG binds to muscle fibers (Sabbatini et al. 1999). 
Moreover, in a study on the origin of skeletal muscle HRG, we have demonstrated that muscle cells 
do not synthesize the protein but instead can actively internalize it from plasma, indicating for the 
first time that HRG can be carried to tissues via circulation (Sabbatini et al. 2011). We have also 
described a positive correlation in human skeletal muscle between the content of HRG and the level 
of AMPD1 activity that it is known to be predominant in type IIB fast-twitch glycolytic fibers 
(Sabbatini et al. 1999, 2006).  
 4 
This paper reports the results of an immunohistochemical study carried out to investigate the 
subcellular localization of HRG in human skeletal muscle. In particular, the HRG distribution at the 
sarcomeric level was evaluated and also compared to that of AMPD1. 
 
MATERIALS AND METHODS   
Antibodies and reagents  
Rabbit anti-HRG polyclonal antibody (HRG-462) raised against the C-terminal region (residues 
462-471) of human plasma HRG and rabbit anti-human AMPD1 polyclonal antibody were 
produced in-house as previously described (Sabbatini et al. 1999, 2006). Rabbit anti-HRG 
polyclonal antibody (HRG-256) against the 256-270 region of human plasma HRG, mouse anti-
skeletal myosin (fast) clone My-32 , that stains the  type II (fast-twich) fibers, and mouse anti-actin 
(α-sarcomeric) monoclonal antibodies were purchased from Sigma-Aldrich (Saint Louis, Missouri, 
USA). Alexa Fluor® 488 goat anti-rabbit IgG (H+L) and Alexa Fluor 568 donkey anti-mouse IgG 
secondary antibodies (for optical immunofluorescence microscopy), Alexa Fluor 488 goat anti 
mouse IgG and Alexa Fluor® 568 donkey anti-rabbit IgG secondary antibodies (for confocal 
microscopy) were purchased from Invitrogen (Carlsbad, California, USA). Nuclear dye TO-PRO 
(TO-PRO®-3stain) was from Life Technologies Italia (Monza, MB, Italy). All other reagents were 
of analytical grade and were purchased from Sigma-Aldrich and  Fluka (Buchs, Switzerland). 
 
Sample collection 
Three muscle biopsies, one from gastrocnemius (male, patient age = 28), and two from quadriceps 
femoris  (females, patient age = 69 and 78), were selected among frozen muscle samples from the 
archives of Division of Pathology, Department of Surgical, Medical, Molecular Pathology and 
Critical Care, University of Pisa. Serial sections of 8 µm were cut in a cryostat at -20 °C and 
processed for routine histological and histochemical stains, i.e. hematoxylin-eosin, succinate 
dehydrogenase, NADH tetrazolium reductase, routine ATPase (pH 9.4), ATPase pre-incubated at 
pH 4.3 and 4.6 (Dubowitz and Brooke, 1973) and for immunofluorescence microscopy. All the 
procedures performed in the present study involving human participants were in accordance with 
the 1964 Helsinky Declaration and its later amendments. 
 
Immunofluorescence Microscopy 
Tissue sections were fixed in cold acetone/methanol (1:1 v/v) for 10 min at -20 °C, washed in 
phosphate buffered saline (PBS) and incubated with 0.2% Triton-X100 in PBS for 10 min. After 
one hour in blocking solution (0.1% Tween, 0.25% BSA in PBS) slides were incubated for 16 hours 
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at 4 °C with primary antibodies diluted in blocking solution as follows: anti-human HRG polyclonal 
antibodies (1:500), anti-myosin My-32 monoclonal antibody (1:750), anti-actin (α-sarcomeric) 
monoclonal antibody (1:300), anti AMPD1 polyclonal antibody (1:400). Slides were then washed 
three times with blocking solution and incubated for 1.5 hours in the dark with relative fluorescent 
secondary antibodies diluted 1:250 in blocking solution. For confocal microscopy, nuclear staining 
was performed by TO-Pro. Samples were mounted with PBS-glycerol solution. All steps were 
performed at room temperature unless otherwise specified. Negative controls for secondary 
antibodies were performed omitting primary antibodies and incubating the specimens with 
nonimmune serum. The specificity of the produced in-house primary antibodies was previously 
tested by Western blot analysis (Sabbatini et al. 1999, 2006) and, in the present study, by anti-HRG 
and anti-AMPD1 immunoglobulins pre-adsorbed for 16 hours at 4 °C with a ten fold excess of the 
respective blocking peptides, i.e. the synthetic peptide used for rabbit immunization. The analysis of 
immunofluorescence pattern was performed in at least three non-consecutive sections for each 
sample. Specimens were observed by a Zeiss Axioplan microscope, equipped with a Nikon digital 
camera, using x40 or x100 oil immersion lenses or by confocal laser scanning microscopy (TC 
SSP8 Leica Microsystems, Mannheim, Germany) using a x63 oil immersion lens and 488 nm, 561 
nm and 642 nm excitation wavelength lasers. Confocal multiple optical sections (Z planes = 23, z-
step = 0.35μm) were used to obtain the maximum intensity projections and the isosurface 
representation showed in the present paper.  
 
RESULTS AND DISCUSSION 
We have provided the first evidence for the presence of HRG in human skeletal muscle (Sabbatini 
et al. 1999).  Moreover, we have shown that muscle cells do not synthesize the protein but instead 
can actively internalize it from plasma, demonstrating for the first time that HRG can be carried to 
tissues via the circulation (Sabbatini et al. 2011). Our results have been confirmed by recent in vivo 
experiments with radiolabeled HRG showing that, after intravenous injection, HRG was 
internalized quickly in healthy tissues, including muscle, and in tumors (Tugues et al. 2014). 
At present no information is reported in literature about the subcellular localization of HRG in 
muscle fibers. To address this issue we carried out the present immunohistochemical study on three 
biopsies of human skeletal muscle.  
The muscle fibers of the three specimens, that showed no histological or histochemical 
abnormalities, appeared highly contracted. Comparable immunohistochemical results were obtained 
for all the tested antigens using each of the three biopsies. The immunohistochemical analysis for 
HRG was performed using both the HRG-462 and the commercial HRG-256 antibodies that 
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showed the same pattern of positive staining in all the samples analyzed. Fig. 1a shows as an 
example the staining obtained in optical fluorescence microscopy using the two anti-HRG 
antibodies. Neither autofluorescent nor immunofluorescent signals could be observed in negative 
controls with 488 nm, 561 nm and 642 nm excitation lasers. 
By optical fluorescence microscopy all the cross sections exhibited a diffuse, uniform 
immunoreactivity for HRG in the connective tissue among the muscle fibers. Conversely, within the 
fibers a speckled staining pattern characterized by dots, lines or star-shaped structures was observed 
(Fig. 1a). According to the intensity of sarcoplasmic fluorescence, two fiber-types could be 
distinguished, one weakly stained and another with a stronger signal due to more abundant, larger 
and brighter granulations. Double immunofluorescence with anti-HRG and anti-myosin My-32 
antibodies evidenced, in  cross sections, a granular pattern for HRG that filled the sarcoplasmic 
spaces free from myosin (Fig. 1b). Moreover, the highest HRG positivity was observed in type II 
fibers, in agreement with our previous observations (Sabbatini et al. 1999). The same double 
immunoreaction, performed on longitudinal sections (Fig. 1c), showed a cross-striation pattern for 
HRG at the myofibrillar level. The HRG signal was alternated to that of myosin suggesting an 
association of HRG to the I-band although an overlapping of the two signals at the border between 
the I-band and the A-band cannot be excluded.  
The sarcomeric localization of HRG observed with the light microscope was further characterized 
by confocal laser scanning microscopy (Fig. 2). The sarcomeric structure was identified evidencing 
the I-band by the anti-actin antibody whilst the periphery of the A-band was evidenced by the anti-
myosin My-32 antibody (Fig. 2a). The double staining carried out with the anti-HRG antibody and 
the anti-myosin or the anti-actin antibody confirmed the localization of HRG at the level of the I-
band. In particular, the longitudinal sections showed a specific, periodic distribution of HRG over 
the muscle fiber that consisted of sharp, fluorescent bands. The bands were as wide as the whole I-
band of the sarcomere, making contact with the ends of the A-band (Fig. 2a, b). Both in longitudinal 
and in cross sections, HRG showed the same sarcomeric localization of actin although the two 
proteins did not co-label as evidenced  in merged images (Fig. 2a-d).  
Our investigation was also addressed to compare the subcellular localization of HRG and AMPD1 
as we have previously described the association of HRG with purified rabbit AMPD1 (Ranieri-
Raggi et al. 1997, 2003) and showed that an anti-HRG antibody bound mainly to type IIB fibers of 
human skeletal muscle that are well known to contain the highest level of AMPD1 activity 
(Sabbatini et al. 1999). All the longitudinal sections analyzed by confocal microscopy showed a 
periodical distribution of AMPD1 over the muscle fibers. Specifically, at sarcomeric level the 
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AMPD1 staining was very strong all over the I-band, similarly to the distribution of HRG, although 
a positive staining could also be clearly detected into the A-band (Fig. 3). 
The observation that AMPD1 is detectable into the A-band is in agreement with Ashby et al. (1979) 
and van Kuppevelt et al. (1994) that describe the enzyme, in unstretched/contracted muscle, 
predominantly over the I-band and to a minor extent in the middle of the A-band and, in stretched 
muscles, at the boundary of A- and I-band. It should be noted that AMPD1 has been found to bind 
native myosin and purified myosin S2 fragments (Ashby and Frieden 1977, Ashby et al. 1979). It 
has also been suggested that AMPD1 may be attached to the myofibrils through titin molecules and 
this immobilization could improve its metabolic efficiency (Cooper and Trinick 1984). However, 
no clear influence on AMPD1 activity has been found as a result of the interaction of the enzyme 
with either titin or myosin. In contrast, an involvement of the N-terminal Zn-binding region of 
troponin T (TnT) in the modulation of AMPD1 activity has been observed in vitro (Ranieri-Raggi et 
al. 1985) that let us to suppose that an interaction between the N-terminal Zn-binding regions of 
AMPD1 and TnT could also occur in vivo (Ronca and Raggi 2017). In the light of the results of this 
paper, the different sarcomeric distribution of HRG and AMPD1 together with their co-localization 
at the I-band suggests that HRG might move from extracellular space to sarcoplasm and myofibrils 
through Tranverse tubuls, accumulating primarily at the triad level where it can supply zinc to 
AMPD1, by acting as zinc chaperone. 
The main result of the present study remains the observation of a preferential localization of HRG 
at the sarcomeric I-band. This finding deserves consideration as it suggests that HRG could interact 
with proteins that take part to the constitution of the thin filament. The data of the literature 
mentioned below support this hypothesis. First, an interaction between HRG and sarcomeric 
tropomyosin could take place in the light of the observation that HRG binds with high affinity and 
in a Zn
2+
 or pH dependent manner to tropomyosin present on the surface of the FGF-2-activated 
HUVEC cell (Guan et al. 2004). Secondly, an interaction between HRG and a component of the 
troponin complex, namely TnT, could also be hypothesized. The N-terminal region of fast skeletal 
TnT contains a putative zinc-binding site (Ronca and Raggi 2017). Interestingly, it has been 
reported that the AMPD1 allosteric properties, removed by limited proteolysis of the N-terminal 
region of the enzyme, can be restored by TnT or the phosphorylated N-terminal region of TnT 
(Ranieri-Raggi et al. 1985). HRG is a regulatory component of AMPD1 and, behaving as zinc 
metallochaperone, may enhance the in vivo AMPD1 stability through insertion of zinc, essential for 
its activity, or modulating its intracellular availability (Mangani et al. 2003, 2007; Martini et al. 
2007). Therefore it could be hypothesized that the unrestrained AMPD1 activity that follows the N-
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terminus proteolytic cleavage of the enzyme in strenuously exercised muscle could be counteracted 
by the binding of HRG-AMPD1 to TnT (Ronca and Raggi 2017).  
The present paper also shows a nuclear localization of HRG (Fig 2e). This observation deserves 
consideration since HRG regulates numerous biological activities including cell adhesion and cell 
proliferation. In particular, a relationship between HRG and rearrangement of actin cytoskeleton 
has been described. On human lymphocytes and leukemic T-cell line, HRG promotes 
morphological changes that are associated not only with the formation of pseudopodia-like 
structures but also with an increase in the F-actin rich surface protrusion (Ohta et al. 2009). 
Furthermore, it has been described that HRG, by inducing focal adhesion kinase phosphorylation, 
targets focal adhesions in endothelial cells disrupting the actin stress fibers formation and therefore 
exhibiting an antiangiogenic activity (Lee et al. 2006). 
Further studies will be necessary to deepen the ultrastructural localization of HRG in muscle fiber, 
both at sarcomeric and nuclear level, as well as to better clarify its possible role in relation to gene 
transcription and regulation.  
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Fig.1 
Immunofluorescence microscopy: representative images of human skeletal muscle sections treated 
with anti-HRG and anti-myosin antibodies. Individual fluorescent channels: green (HRG) and red 
(myosin). (a) Cross sections incubated with HRG-462 or HRG-256 antibody. (b) Double 
immunofluorescence with HRG-462 and My-32 antibodies, performed on cross sections. I, type I 
muscle fiber; II, type II muscle fiber. (c) Double immunofluorescence with HRG-462 and My-32 
antibodies, performed on longitudinal sections. Scale bars 100 µm for a, 50 µm for b, 10 µm for c 
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Fig.2  
Confocal laser scanning microscopy: representative images of human skeletal muscle sections 
treated with HRG-462, anti-myosin and anti-actin antibodies. Individual fluorescent channels: red 
(HRG), green (myosin and actin) and blue (nuclei). (a) Three-dimensional picture of the maximum 
intensity projection of the raw images of longitudinal sections; capital letters A and I indicate the A-
band and the I-band, respectively. (b) Images acquired in one Z-plane. The arrows point out the 
contact of HRG with the ends of the A-bands. The distribution of HRG is similar to that of actin. (c) 
Three-dimensional picture of the maximum intensity projection of the raw images of a cross 
section. HRG and actin, although closely associated, do not co-label (see arrows) as it is also 
evidenced in (d) by the isosurface representation. (e) The bi-dimensional image of the maximum 
intensity projection allows to observe the HRG immunopositivity also in the nuclei (arrowheads) as 
evidenced by the color overlap of the blue (nuclei) and red (HRG) fluorescent channels. Scale bars  
2.5 µm for a and b, 10 µm for c and e 
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Fig.3 
Confocal laser scanning microscopy: representative images of a human skeletal muscle myofibril 
treated with anti-AMPD1 (red) and My-32 (green) antibodies. In the longitudinal section, the 
AMPD1 staining is present all over the I-band (see arrows) as well as into the A-band (see 
arrowheads). Capital letters A and I indicate the A-band and the I-band, respectively. Scale bar  2.5 
µm  
 
 
 
 
 
